https://techpapersworld.com/wp-content/uploads/2022/09/Chi-Biotech-Launches-Free-To-Use-Next-Gen-1280x720.jpg

Chi-Biotech Co. Ltd. (“Chi-Biotech” or “the Company”) announced that after two years of efforts, it has successfully deployed its FANSe-based next-generation sequencing analysis solution on Amazon Web Services (AWS). The free-of-charge, accurate solution is now available to customers globally, which can significantly reduce costs and increase efficacy for precision medicine and scientific research around the globe. Next-generation sequencing (NGS) parallelly sequences billions of DNA fragments. Aligning these reads to reference genome is the first step...